DPDPE vs Calcitonin
Head-to-head comparison of DPDPE ([D-Pen2, D-Pen5]-enkephalin) and Calcitonin (Salmon Calcitonin) — benefits, dosing, side effects, research data, and where to buy.
Research Score
| Property | DPDPE | Calcitonin |
|---|---|---|
| Category | Pain Management | Pain Management |
| Full Name | [D-Pen2, D-Pen5]-enkephalin | Salmon Calcitonin |
| Molecular Weight | 645.79 Da | 3431.9 Da |
| Half-Life | 15-60 minutes in plasma | about 10-15 minutes |
| Amino Acids | 5 | 32 |
| Typical Dose | 0.01-1 ug per animal | 100 IU/day SC or 200 IU/day intranasal |
| Route | Intrathecal / intracerebroventricular | Intranasal/Subcutaneous |
| Purity | ≥98% | ≥98% |
| Studies Count | 800 | 350 |
| Research Status | Pre-clinical | Approved |
DPDPE Benefits
- ✓delta-opioid selectivity
- ✓improved conformational stability
- ✓analgesic receptor mapping
- ✓useful in chronic pain models
Calcitonin Benefits
- ✓bone pain relief
- ✓short-term analgesic effect
- ✓may reduce opioid requirement
- ✓useful in osteoporotic fracture pain
DPDPE Dosing
Intrathecal 0.01-1 ug per animal|Intracerebroventricular 0.01-0.5 ug per animal|In vitro 0.1-20 nM
Calcitonin Dosing
100 IU subcutaneous daily|200 IU intranasal daily|short-term use in acute pain settings
DPDPE Side Effects
- ⚠sedation
- ⚠nausea-like opioid effects
- ⚠tolerance with repeated dosing
Calcitonin Side Effects
- ⚠nausea
- ⚠flushing
- ⚠rhinitis
Research Overview
DPDPE
DPDPE is widely cited in opioid pharmacology because it helped establish the functional role of delta-opioid receptors in pain control. Its constrained structure is also used to explore how peptide cyclization changes potency, stability, and tissue selectivity.
Calcitonin
Calcitonin has been evaluated in randomized trials and reviews for pain associated with vertebral compression fractures and other bone-related conditions. The signal is strongest for short-term analgesia rather than long-term chronic pain control.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.